Menu
Back to User profile » Dr Yanliang Bai
Papers published by Dr Yanliang Bai:
The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients
Dou L, Shi M, Song J, Niu X, Niu J, Wei S, Li D, Bai Y, Sun K
Cancer Management and Research 2022, 14:303-316
Published Date: 25 January 2022
Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia
Pei Y, Shi M, Song J, Niu X, Wei S, Dou L, Xiao M, Li D, Xu F, Bai Y, Sun K
Cancer Management and Research 2021, 13:4135-4146
Published Date: 21 May 2021
Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study
Yang X, Bai Y, Shi M, Zhang W, Niu J, Wu C, Zhang L, Xu Z, Liu X, Chen Y, Sun K
Cancer Management and Research 2020, 12:1293-1301
Published Date: 20 February 2020
The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
Shi M, Xu F, Yang X, Bai Y, Niu J, Drokow EK, Chen M, Chen Y, Sun K
Cancer Management and Research 2019, 11:8229-8238
Published Date: 6 September 2019
iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia
Yu R, Zhang J, Zang Y, Zeng L, Zuo W, Bai Y, Liu Y, Sun K, Liu Y
Cancer Management and Research 2019, 11:7047-7063
Published Date: 25 July 2019